Project memberTeaching Assistant Marko Jankovic

Laboratory research activities. Project dissemination. Reporting of project results. Writing and manuscript revision.

+381 63 735 77 99










SKILLSAbout Teaching Assistant Marko Janković

Medical Doctor, employed as a Teaching Assistant at the Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade. Currently undertaking doctoral studies in Molecular medicine. Previously engaged as MD at the Clinic for infectious and tropical diseases, Belgrade, Serbia. Interests include virology, genetics, infectious diseases, transplantation microbiology.

Molecular microbiology techniques, Gel electrophoresis

Viruses are constantly evolving. Our strategies to discover, monitor and study them must perpetually evolve as well.
Teaching Assistant Marko Janković
Project member


My research is primarily centered on the human cytomegalovirus (HCMV) infection in adult and pediatric patients with stem cell transplant, with particular focus on investigating the relation between HCMV genotypes and clinical manifestations, as well as the role of HCMV in oncogenesis. In addition to teaching and scientific work, as a medical doctor I actively partake in diagnostics of human viral infections. Until now I took part in a project by the Ministry of science and technological development of the Republic of Serbia („Medical significance of genetic variability of viruses“, project no. 1750-73), and am currently active on three more projects as well, two of which by the Science Fund of the Republic of Serbia („An evolutionary insight into molecular diversity of emerging pathogens in Serbia through phylogenetic approach“ [IN-DEPTH]; Program for excellent projects of young researchers (PROMIS) project grant no. 6059147 and „Continuous inactivation and removal of SARS-CoV-2 in indoor air by ionization“ [idCOVID], grant no. 7552286) and one by the Government fo the Republic of Serbia („National study of seroprevalence and molecular characterization of SARS-CoV-2 during the epidemic in the population of Serbia ([EPI-COVID-SRBIJA]“)


Serbian Medical Society, Serbian Society for Microbiology


Jovanović T, Janković M, Knežević A. Emerging variants of novel coronavirus – myth and reality. Srpski arhiv za celokupno lekarstvo. doi: 10.2298/SARH210206026J

  1. Božić Lj, Jovanović T, Šmitran A, Janković M, Knežević A. Comparison of HPV detection rate in formalin‐fixed paraffin‐embedded tissues of head and neck carcinoma using two DNA extraction kits and three amplification methods. Eur J Oral Sci. 2020;1-7.
  2. Janković M, Ćupić M, Knežević A, Vujić D, Soldatović I, Zečević Ž, Gobeljić B, Jovanović T. Cytomegalovirus glycoprotein B and N genotypes in pediatric recipients of the hematopoietic stem cell transplant. Virology. 2020;548:168-173. doi:10.1016/j.virol.2020.07.010
  3. Janković M, Jovanović T. Cytomegalovirus: A Tale of Resistance. Med Podml. 2019;70(4):21-26. doi:10.5937/mp70-23493
  4. Jovanović T, Ćupić M, Knežević A, Stanojević M, Lazarević I, Banko A, Miljanović D, Janković M. Racionalna primena virusološke dijagnostike u laboratorijskim radu. Acta Clinica. 2018;18(1): 73-79.
  5. Colovic N, Lekovic D, Jankovic M, Dencic MF, Gotic M. T Lymphoblastic Transformation of chronic Myeloid Leukemia with Isolated Maturing Precursors of Neutrophil Cell line in the Cerebrospinal Fluid. Int J Case Rep Short Rev. 2017;3(2): 027-030.
  6. Čolović N, Janković M, Leković D, Gotić M. Vojislav Arnovljević described “Sézary syndrome” ten years before Sézary and Bouvrain. Srp Arh Celok Lek. 2016;144(9-10): 557-561.
  7. Jurišić V. Plećić M, Čolović N, Čemerikić-Martinović V, Janković M, Čolović M. MUM-1 and bcl-2 Positive Primary Diffuse Large B Cell Non-Hodgkin’s Lymphoma of the Colon. Arch Iran Med. 2016;19(4): 297-299.
  8. Janković М, Svetel М, Kostić V. Frequency of REM Sleep Behavior Disorders in Patients with Parkinson’s Disease. Vojnosanit Pregl. 2015;72(5): 442-446.
  9. Čolović M, Vidović A, Janković M, Čolović N, Peruničić Jovanović M. Myeloid sarcoma of the testis and skin with osteolytic bone lesions in blastic transformation of primary myelofibrosis. Lab Med. 2013;44: 258-261.
  • Fund for Science and Art Youth of the Republic of Serbia Stipend

2017 – ongoing                 Specialization in Medical microbiology; Faculty of Medicine, University of Belgrade.

2015 – ongoing                 Doctoral studies; module ”Molecular medicine’, Faculty of Medicine, University of Belgrade.

2006 – 2012                      Integrated academic studies of Medicine; Faculty of Medicine, University of Belgrade.